Article Details

PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB ...

Retrieved on: 2021-08-11 11:03:45

Tags for this article:

Click the tags to see associated articles and topics

PureTech Announces That Imbrium Therapeutics Has Exercised License Option to LYT-503/IMB .... View article details on hiswai:

Excerpt

LYT-503/IMB-150 leverages the Alivio TM platform technology and is designed to selectively bind to and treat inflamed tissue along the bladder wall ...

Article found on: www.kulr8.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up